Argent Biopharma Ltd (RGT.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Sales | 2,079 | 656 | 297 | 120 | N/A |
| Cost of Goods | 1,905 | 357 | 119 | 158 | 15 |
| Gross Profit | 175 | 300 | 177 | -38 | -15 |
| Operating Expenses | 11,979 | 9,339 | 7,438 | 7,282 | 4,363 |
| Operating Income | -11,805 | -9,039 | -7,261 | -7,320 | -4,378 |
| Interest Expense | 136 | 8 | 99 | 20 | 120 |
| Other Income | -6,874 | 7,171 | -1,630 | -1,163 | -1,732 |
| Pre-tax Income | -18,814 | -1,876 | -8,990 | -8,502 | -6,230 |
| Income Tax | 0 | 27 | -1 | 0 | 0 |
| Net Income Continuous | -18,814 | -1,904 | -8,989 | -8,502 | -6,230 |
| Net Income Discontinuous | -556 | -450 | N/A | N/A | N/A |
| Minority Interests | 7 | 45 | 743 | 358 | 73 |
| Net Income | $-19,363 | $-2,309 | $-8,246 | $-8,144 | $-6,157 |
| EPS Basic Total Ops | -14.00 | -1.90 | -7.30 | -8.40 | -10.30 |
| EPS Basic Continuous Ops | -13.60 | -1.60 | -7.30 | -8.40 | -10.30 |
| EPS Basic Discontinuous Ops | -0.40 | -0.40 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -14.00 | -1.90 | -7.30 | -8.40 | -10.30 |
| EPS Diluted Continuous Ops | -13.61 | -1.60 | -7.30 | -8.40 | -10.30 |
| EPS Diluted Discontinuous Ops | -0.40 | -0.40 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $-18,198 | $-1,609 | $-8,563 | $-8,399 | $-6,093 |